About this trial
This study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Written Exposure Therapy for PTSD and delivered in an accelerated (i.e., 5-day) group treatment format, preceded and followed by individual treatment sessions. 160 participants will be randomized into one of two study conditions.
Eligibility criteria
Qualifiers
Defense Enrollment Eligibility Reporting System (DEERS) eligible active-duty military personnel or veteran, 18-65 years old.
Ability to speak and read English.
Clinically significant PTSD symptoms (CAPS-5 > 25 with at least one Intrusion symptom and at least one Avoidance symptom).
Clinically significant symptoms of insomnia disorder (Structured Clinical Interview for Sleep Disturbance DSM-5 (SCISD) Insomnia Criteria are met and Insomnia Severity Index (ISI) > 11).
Disqualifiers
Current suicide or homicide risk meriting crisis intervention.
Inability to comprehend the baseline screening questionnaires.
Unwilling to remain abstinent from alcohol during therapy sessions.
Serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders warranting immediate clinical attention based on interviewer assessment and clinical judgement.
Trial design
Treatments tested in this trial
- Cognitive-Behavioral Therapy for Insomnia (CBTi)
- Cognitive Behavioral Therapy for Nightmares (CBTn)
- Written Exposure Therapy (WET)
- Sleep Hygiene
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and collaborators
Palo Alto Veterans Institute for Research
Lead sponsor
The University of Texas Health Science Center at San Antonio
Collaborator
University of Arizona
Collaborator
NDRI-USA, Inc.
Collaborator